CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Revenues	$ 3,017,489	$ 2,262,090	$ 5,504,385	$ 4,223,877
Cost of goods sold	334,829	157,982	624,169	368,894
Gross profit	2,682,660	2,104,108	4,880,216	3,854,983
Operating expenses
Selling, general and administrative expense	2,983,248	2,048,300	5,333,611	3,702,661
Depreciation and amortization	22,542	21,828	26,882	42,076
Bad debt expense	0	3,000	0	12,558
Total operating expenses	3,005,790	2,073,128	5,360,493	3,757,295
Operating income (loss)	(323,130)	30,980	(480,277)	97,688
Other income / (expense)
Other income (expense)	145	193	145	302
Interest expense	(29,486)	0	(34,911)	(60,608)
Total other income (expense)	(29,341)	193	(34,766)	(60,306)
Net income (loss)	(352,471)	31,173	(515,043)	37,382
Less: Net income (loss) attributable to noncontrolling interest	(1,054)	0	(1,054)	0
Net income (loss) attributable to Sanara MedTech Inc.	(351,417)	31,173	(513,989)	37,382
Series C preferred stock dividends	0	0	0	(28,061)
Series C Preferred Stock inducement dividends	0	0	0	(103,197)
Net loss attributable to common stockholders	$ (351,417)	$ 31,173	$ (513,989)	$ (93,876)
Basic income per share of Common stock	$ (0.15)	$ 0.01	$ (0.37)	$ (0.05)
Diluted income per share of Common Stock	$ (0.15)	$ 0.01	$ (0.37)	$ (0.05)
Weighted average number of common shares outstanding basic	2,366,288	2,366,429	1,398,867	1,973,613
Weighted average number of common shares outstanding diluted	2,366,288	2,366,429	1,398,867	1,973,613